Open original FDA record ↗Recall record
- FDA identifier
- Z-1296-2018
- Company in FDA record
- Magellan Diagnostics, Inc.
- FDA record creation date
- Apr 3, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The incorrect placement of AA batteries into certain LeadCare Plus Blood Lead Analyzer may cause the batteries to overheat, and the chance that a user could burn their fingers if the batteries are removed while hot.
Source facts
- Action
- An Urgent Medical Device Correction letter, dated January 9, 2018, was sent to customers. The letter identified the affected device and provided a description of the issue. If two of the four AA batteries are inserted incorrectly, the batteries may overheat, causing a minor burn if the user opens the battery compartment and tries to remove the hot batteries. Customers are to follow the steps outlined in the letter, including placing the enclosed label on the upper back panel of the analyzer to remind users who are changing batteries of the importance of correct placement. Proper battery placement should be provided in annual training. Customers are to complete and return the acknowledgement card. Please direct any questions to 800-275-0102 or LeadCareSupport@magellandx.com.
- Initiated
- 2018-01-09
- Root cause
- Device Design
- Terminated
- 2020-12-11
- Distribution
- Worldwide Distribution
- Recall number
- Z-1296-2018
- Recall status
- Terminated
- CDRH record ID
- 161822
- FDA record created
- 2018-04-03
- Recall event number
- 79279